BSX

BOSTON SCIENTIFIC CORP

BSX·101137107·US·Common Stock·Healthcare - Medical Devices-13D/G

BSX (BOSTON SCIENTIFIC CORP) is held by 357 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($5.5B), VANGUARD CAPITAL MANAGEMENT LLC ($4.1B), STATE STREET CORP ($3B). Net institutional sentiment: Mixed. In Q2 2026, 7 members of Congress and 166 funds bought BSX.

357
Holders
(33 Elite)
$51.2B
Total Value
45% (369)
Consensus
166 buying - 203 selling
13F: Insider & Congress: Updated regularly
BSX

Smart Money Verdict

View all
Loading verdict
Held by 357 funds
33 elite

Who's Trading

Source dates: Price Sep 1, 2026 · Insiders Aug 26, 2026 · Activists Aug 6, 2026 · Congress Jul 21, 2026

InsiderMEMorano Susan EBuy $100KAug 25, 2026
ActivistFMR LLCFMR LLC3.1%Aug 6, 2026
CongressGilbert CisnerosGilbert CisnerosSale $1,001 - $15,000Jun 5, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
129.7M(-1.6%)$5.5B0.1%-48.04%
0
Increased
97.1M(+0.7%)$4.1B0.1%-25.19%
32
Increased
70.1M(+3.1%)$3B0.1%-21.78%
33
Increased
50.5M(+55.3%)$2.2B1.3%+19.48%
71
Decreased
45.7M(-38.4%)$2B0.1%-47.56%
0
Increased
24.9M(+126.1%)$1.5B0.5%+11.08%
62
Increased
33.4M(+0.5%)$1.4B0.1%-5.37%
32
Decreased
29.8M(-0.0%)$1.3B0.1%-25.35%
0
Increased
25.5M(+4.7%)$1.1B0.5%-39.82%
47
Decreased
23.9M(-28.3%)$1B0.1%-46.22%
0
Increased
23.3M(+67.7%)$994.2M0.4%-21.55%
56
Increased
19.4M(+105.7%)$826.2M0.6%-16.88%
72
Decreased
18.9M(-14.9%)$808.7M0.0%-42.58%
0
Decreased
17M(-10.3%)$723.6M0.1%-46.58%
0
Increased
16.8M(+9.8%)$717.6M0.1%-32.66%
35
Increased
16.4M(+10.3%)$697.9M0.1%-34.62%
35
Decreased
15.3M(-18.8%)$653.1M0.1%-17.62%
0
Increased
14.3M(+1.2%)$610.2M0.1%-24.05%
38
Increased
14.2M(+100.3%)$605.3M0.1%-26.26%
51
Increased
13.8M(+52.5%)$589M0.0%-11.06%
44

Showing 1-20 of 384

1 / 20
BSXBSXBOSTON SCIENTIFIC CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used